LipocineLPCN
13F holders, Q2 2025 (June 30)18holders −1
1new positions
2sold out
1famous investor
$3.16avg. 13F price*
At the end of Q2 2025, 18 institutions reported holding Lipocine Inc. (LPCN) in their 13F filings, down 1 from Q1 2025. 1 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($711K), BlackRock, Inc. ($282K) and Geode Capital Management, LLC ($193K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lipocine Inc.
- CUSIP
- 53630X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $30K |
| Exits | 2 | $789 |
All 13F filers, Q1 2025 → Q2 2025: 19,016 shares bought and 8,033 shares sold, net +10,983 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.6% | 224,876 | $711K |
| BlackRock, Inc. | 0.00% | No change | 89,272 | $282K |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 61,076 | $193K |
| Susquehanna International Group, LLP | 0.00% | Add +18.1% | 46,019 | $145K |
| Renaissance Technologies | 0.00% | Reduce -7.2% | 34,797 | $110K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -4.3% | 23,862 | $75K |
| State Street Corp. | 0.00% | No change | 18,626 | $59K |
| Northern Trust Corp. | 0.00% | No change | 13,160 | $42K |
| Barclays PLC | 0.00% | New | 9,412 | $30K |
| Bank of America Corp. | 0.00% | Add +0.2% | 2,587 | $8K |
| Osaic Holdings, Inc. | 0.00% | Add +1.8% | 2,287 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -45.6% | 673 | $2K |
| Morgan Stanley | 0.00% | Reduce -77.7% | 575 | $2K |
| UBS Group AG | 0.00% | Add +138.7% | 475 | $2K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 471 | $1K |
| Group One Trading LLC | 0.00% | Reduce -17.8% | 162 | $512 |
| SBI Securities Co., Ltd. | 0.00% | No change | 67 | $212 |
| Tidemark, LLC | 0.00% | No change | 59 | $186 |
"% of holder's portfolio" is LPCN's weight in each manager's 13F, not the share of Lipocine Inc. the manager owns.